GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TOT Biopharm International Co Ltd (HKSE:01875) » Definitions » Days Sales Outstanding

TOT Biopharm International Co (HKSE:01875) Days Sales Outstanding : 43.58 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is TOT Biopharm International Co Days Sales Outstanding?

TOT Biopharm International Co's average Accounts Receivable for the six months ended in Dec. 2024 was HK$147 Mil. TOT Biopharm International Co's Revenue for the six months ended in Dec. 2024 was HK$617 Mil. Hence, TOT Biopharm International Co's Days Sales Outstanding for the six months ended in Dec. 2024 was 43.58.

The historical rank and industry rank for TOT Biopharm International Co's Days Sales Outstanding or its related term are showing as below:

HKSE:01875' s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.59   Med: 41.9   Max: 63.81
Current: 40.14

During the past 8 years, TOT Biopharm International Co's highest Days Sales Outstanding was 63.81. The lowest was 25.59. And the median was 41.90.

HKSE:01875's Days Sales Outstanding is ranked better than
76.33% of 845 companies
in the Biotechnology industry
Industry Median: 69.43 vs HKSE:01875: 40.14

TOT Biopharm International Co's Days Sales Outstanding increased from Dec. 2023 (31.52) to Dec. 2024 (43.58).


TOT Biopharm International Co Days Sales Outstanding Historical Data

The historical data trend for TOT Biopharm International Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOT Biopharm International Co Days Sales Outstanding Chart

TOT Biopharm International Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial 63.81 31.62 25.59 31.78 40.62

TOT Biopharm International Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.94 33.57 31.52 36.02 43.58

Competitive Comparison of TOT Biopharm International Co's Days Sales Outstanding

For the Biotechnology subindustry, TOT Biopharm International Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOT Biopharm International Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TOT Biopharm International Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where TOT Biopharm International Co's Days Sales Outstanding falls into.


;
;

TOT Biopharm International Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

TOT Biopharm International Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (93.834 + 167.154) / 2 ) / 1172.655*365
=130.494 / 1172.655*365
=40.62

TOT Biopharm International Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (127.416 + 167.154) / 2 ) / 616.822*365 / 2
=147.285 / 616.822*365 / 2
=43.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TOT Biopharm International Co  (HKSE:01875) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


TOT Biopharm International Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of TOT Biopharm International Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


TOT Biopharm International Co Business Description

Traded in Other Exchanges
N/A
Address
120 Changyang Street, Suzhou Industrial Park, Suzhou, CHN, 215024
TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families as well as medical professionals. It has a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). It generates revenues from Mainland China.
Executives
Center Laboratories, Inc. 2201 Interest of corporation controlled by you
Tricor Trust (hong Kong) Limited 2301 Trustee
Chengwei Evergreen Capital, Lp 2101 Beneficial owner
Center Laboratories Inc. 2101 Beneficial owner
Chengwei Evergreen Management, Llc 2201 Interest of corporation controlled by you
Suzhou Vivo Management Consulting Partnership (limited Partnership)
Vivo (suzhou) Health Industry Investment Fund (limited Partnership)
Vivo Capital Llc
Vivo Capital Viii, Llc
Vivo Capital Fund Viii, L.p.
Prime Success International Limited 2101 Beneficial owner
Advantech Capital Ii L.p.
Advantech Capital Ii Master Investment Limited
Advantech Capital Investment V Limited
Advantech Capital Partners Ii Limited

TOT Biopharm International Co Headlines

No Headlines